Market Overview:
The Global Bifurcation Lesions Treatment Market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of bifurcation lesions, technological advancements in bifurcation lesion treatment devices and growing demand for minimally invasive procedures. However, the high cost of these devices may restrain the market growth to some extent. Based on type, the global bifurcation lesions treatment market is segmented into T stent, culotte, crush, V stent, Y stent and jailed balloon. The T stent segment is expected to hold a dominant share in terms of revenue during the forecast period owing to its high adoption rates across various regions worldwide. By application, coronary vascular accounted for majority share in 2017 and this trend is projected continue throughout the forecast period due To rising prevalence of coronary artery diseases (CADs) globally. However; peripheral vascular application would register highest CAGR over 2018-2030 owingto increasing geriatric population susceptible toboth CADs and peripheral arterial diseases (PADs).
Product Definition:
A bifurcation lesion is a type of lesion that occurs at a point where two branches of a blood vessel or other anatomical structure divide. Bifurcation lesions can be dangerous because they can lead to the blockage of one or both branches. Treatment for bifurcation lesions may include surgery, stenting, or other medical interventions.
T Stent:
T Stent is a device used to treat bifurcation lesions, which are also known as forkhead-like papilloma. It is a kind of stent that is used to re-grow the damaged blood vessel and restore blood flow in the affected area. The device works by creating an artificial channel for blood flow through the blockage in the artery wall.
Culotte:
Culotte is a kind of bandage that is used to cover the entire bottom half of the patient's body. It helps in maintaining pressure on the spinal cord and protecting it from injuries. Culotte can be used as an alternative for lumbar spine support devices or as an addition to them.
Application Insights:
The coronary vascular segment dominated the market in 2017 owing to factors such as high prevalence of heart diseases and bifurcation lesions. In addition, increasing adoption of these stents due to their ability to treat both large and small artery bifurcation lesions is expected to drive the segment growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of cardiovascular diseases and increasing adoption of innovative techniques. In addition, presence of key players such as Abbott, Medtronic, Boston Scientific Corporation is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population and improving economic conditions especially in China & Japan. Furthermore, growing medical tourism industry will also boost demand for bifurcation lesions treatment procedures during this period. Growing awareness regarding various treatments available along with availability of cost-effective procedures are some factors driving regional growth at a significant rate during the forecast years from 2018 till 2030 timeframe.
Growth Factors:
- Increasing incidence of bifurcation lesions in patients owing to the rising prevalence of cardiovascular diseases
- Growing demand for minimally invasive procedures for treating bifurcation lesions
- Technological advancements in treatment modalities for bifurcation lesions
- Rising awareness about the benefits of early diagnosis and treatment of bifurcation lesions
- increasing healthcare expenditure by governments and private players
Scope Of The Report
Report Attributes
Report Details
Report Title
Bifurcation Lesions Treatment Market Research Report
By Type
T Stent, Culotte, Crush, V Stent, Y Stent, Jailed Balloon
By Application
Coronary Vascular, Peripheral Vascular
By Companies
Medtronic, Boston Scientific Corporation, Johnson& Johnson Services, Inc, Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Bifurcation Lesions Treatment Market Report Segments:
The global Bifurcation Lesions Treatment market is segmented on the basis of:
Types
T Stent, Culotte, Crush, V Stent, Y Stent, Jailed Balloon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Vascular, Peripheral Vascular
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific Corporation
- Johnson& Johnson Services, Inc
- Abbott
- C. R. Bard, Inc.
- Spectranetics
- Terumo Medical Corporation
- Cardinal Health
Highlights of The Bifurcation Lesions Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- T Stent
- Culotte
- Crush
- V Stent
- Y Stent
- Jailed Balloon
- By Application:
- Coronary Vascular
- Peripheral Vascular
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bifurcation Lesions Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bifurcation lesions are a type of skin lesion that can occur on any part of the body. They are caused by the separation of two layers of skin, which can lead to infection and inflammation. Treatment typically involves antibiotics and/or surgery to close the wound.
Some of the major companies in the bifurcation lesions treatment market are Medtronic, Boston Scientific Corporation, Johnson& Johnson Services, Inc, Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health.
The bifurcation lesions treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bifurcation Lesions Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bifurcation Lesions Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bifurcation Lesions Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bifurcation Lesions Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bifurcation Lesions Treatment Market Size & Forecast, 2020-2028
4.5.1 Bifurcation Lesions Treatment Market Size and Y-o-Y Growth
4.5.2 Bifurcation Lesions Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 T Stent
5.2.2 Culotte
5.2.3 Crush
5.2.4 V Stent
5.2.5 Y Stent
5.2.6 Jailed Balloon
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coronary Vascular
6.2.2 Peripheral Vascular
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bifurcation Lesions Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bifurcation Lesions Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 T Stent
9.6.2 Culotte
9.6.3 Crush
9.6.4 V Stent
9.6.5 Y Stent
9.6.6 Jailed Balloon
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coronary Vascular
9.10.2 Peripheral Vascular
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 T Stent
10.6.2 Culotte
10.6.3 Crush
10.6.4 V Stent
10.6.5 Y Stent
10.6.6 Jailed Balloon
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coronary Vascular
10.10.2 Peripheral Vascular
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 T Stent
11.6.2 Culotte
11.6.3 Crush
11.6.4 V Stent
11.6.5 Y Stent
11.6.6 Jailed Balloon
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coronary Vascular
11.10.2 Peripheral Vascular
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 T Stent
12.6.2 Culotte
12.6.3 Crush
12.6.4 V Stent
12.6.5 Y Stent
12.6.6 Jailed Balloon
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coronary Vascular
12.10.2 Peripheral Vascular
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 T Stent
13.6.2 Culotte
13.6.3 Crush
13.6.4 V Stent
13.6.5 Y Stent
13.6.6 Jailed Balloon
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coronary Vascular
13.10.2 Peripheral Vascular
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bifurcation Lesions Treatment Market: Competitive Dashboard
14.2 Global Bifurcation Lesions Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific Corporation
14.3.3 Johnson& Johnson Services, Inc
14.3.4 Abbott
14.3.5 C. R. Bard, Inc.
14.3.6 Spectranetics
14.3.7 Terumo Medical Corporation
14.3.8 Cardinal Health
